Charming Medical (MCTA) Cash & Equivalents (2025 - 2026)

Charming Medical (MCTA) posted Cash & Equivalents of $4.7 million for Q1 2026, up 164.86% sequentially from $1.8 million in Q3 2025, and up 475.35% YoY from $816771.0 in Q1 2025.

Charming Medical (MCTA) Cash & Equivalents (2025 - 2026) Analysis & Trends

Charming Medical has reported Cash & Equivalents for 2 years, with the latest figure at $4.7 million in Q1 2026.

  • Quarterly Cash & Equivalents rose 475.35% year-over-year to $4.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.7 million (up 475.35% YoY) and the FY2026 annual result came in at $4.7 million, up 475.35% from the prior year.
  • Cash & Equivalents rose to $4.7 million in Q1 2026 per MCTA's latest filing, from $1.8 million in the prior quarter.
  • Over five years, Cash & Equivalents peaked at $4.7 million in Q1 2026 and troughed at $816771.0 in Q1 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 HCA Healthcare 88.19 Bn 90.61 Bn 15.19 Bn 1.01 Bn
2 Tenet Healthcare 21.59 Bn 21.56 Bn 4.45 Bn 2.17 Bn
3 Encompass Health 12.19 Bn 12.86 Bn 1.34 Bn 107.70 Mn
4 Davita 11.52 Bn 12.39 Bn 1.16 Bn 668.96 Mn
5 Ensign 10.59 Bn 10.27 Bn 306.24 Mn 262.30 Mn
6 Universal Health Services 8.79 Bn 8.72 Bn 3.29 Bn 138.80 Mn
7 Pacs 7.04 Bn 6.88 Bn 338.46 Mn 164.45 Mn
8 Chemed 6.96 Bn 6.92 Bn 221.47 Mn 40.22 Mn
9 Concentra Group Holdings Parent 4.52 Bn 4.38 Bn 192.10 Mn 158.04 Mn
10 Charming Medical 445.47 Mn 439.45 Mn - 4.70 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 4.70 Mn
Sep 30, 2025 1.77 Mn
Mar 31, 2025 816,771.00